Crossmark

Initiation of tocilizumab within 24 hours in acute necrotizing encephalopathy is related to a good outcome: a systematic review

Published Online: 2025-09-07

Published Print: 2025-09

Authors

Ju, Yalin

Geng, Chang

Guan, Hongzhi https://orcid.org/0000-0003-3903-5078
Funding

Funding for this research was provided by:

National High Level Hospital Clinical Research Funding (2022--PUMCH-B-120, 2022--PUMCH-B-018)
License Information

Text and Data Mining valid from 2025-09-01

Version of Record valid from 2025-09-01
More Information

Article History

Received: 20 July 2025

Revised: 12 August 2025

Accepted: 23 August 2025

First Online: 7 September 2025

Declarations

:

: On behalf of all authors, the corresponding author states that there is no conflict of interest.

Document is current